Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN DIEGO, July 19, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the second quarter of fiscal 2013 on Monday, August 5.
The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Daylight Time (5 p.m., Eastern Daylight Time), Monday, August 5, hosted by Scott Huennekens, president and chief executive officer, and John Dahldorf, chief financial officer.
The teleconference can be accessed by calling (631) 291-4555, passcode 11845995. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available through the company’s website at www.volcanocorp.com.
A replay of the conference call will be available through Monday, August 12, at (404) 537-3406, passcode 11845995, and via the company’s website.
About Volcano Corporation
Volcano Corporation (Nasdaq: VOLC) is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful informationusing sound and light as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company’s website at www.volcanocorp.com.
SOURCE Volcano Corporation
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
